The repertoire of naturally occurring proteins is limited and many molecules induce multiple conflicting effects. Our group aims to redesign existing proteins and engineer new proteins that overcome these limitations. Combining cutting-edge technologies from structural biophysics, molecular engineering, and translational immunology, we create new platforms for the development of targeted therapeutics to treat a broad range of immune diseases.

News

PJ and Seth's review article

is published. See it here.

Research

Check out our latest projects in molecular immunoengineering

People

Learn more about the research

team in the Spangler group

© 2019 by Spangler Lab.